Stock info Relief Therapeutics | Filter  Basic-Info

Relief Therapeutics

The global health care companies gained over the past 10 years on average 102 percent. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-December 2016) there is a plus of 102 percent.

The past year was a relatively good year for Relief Therapeutics investors

The stock lost over the past 12 months at around 60 percent. Over the past 5 years Relief Therapeutics' stock lost at around 94 percent in value. Relief Therapeutics's net results between 2011 and 2015 were far from constant and moved between -11,83 million CHFF and -4,31 million CHFF.

Relief Therapeutics didn't pay out any dividends (in the past 5 years). Over the past 5 years Relief Therapeutics raised her dividends share each year. Because of the yearly increased dividends Relief Therapeutics can be called a kind of dividend aristocrat.

Relief Therapeutics had about 3417 thousand employees at the end of 2015.

Relief Therapeutics' balance mostly consists of equity

At the end of 2015 the Swiss company's balance sheet was worth 30,34 million CHFF. Last year the total debt of the company was 12,56 million CHFF. This equals around 41,4 percent of the total balance sheet. At the end of 2016 the Swiss company was traded with a price/earnings-ratio of around -7. So investors paid -7 times the company's 2015's EPS. We could say that based on it's price/earnings-ratio and dividend yield the Swiss stock can be seen as a value stock.

At the end of 2015 the health care company's market capitalization (the number of shares times the market price) equaled around 32,58 million CHFF. At the end of 2015 the Swiss company had around 651,62 million stocks listed on the exchanges.

All of Relief Therapeutics's annual reports are stored here. More information about Relief Therapeutics can be found it's website. .